EZH2 Antikörper (N-Term) (FITC)
Kurzübersicht für EZH2 Antikörper (N-Term) (FITC) (ABIN1894420)
Target
Alle EZH2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Human EZH2.
-
Aufreinigung
- Protein G purified
-
Immunogen
-
KLH-conjugated synthetic peptide from the N-terminal region of human EZH2.
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: ELISA, IHC, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, no preservatives added
-
Konservierungsmittel
- Without preservative
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
-
Haltbarkeit
- 6 months
-
-
- EZH2 (Enhancer of Zeste Homolog 2 (EZH2))
-
Andere Bezeichnung
- EZH2
-
Hintergrund
-
Name/Gene ID: EZH2
Synonyms: EZH2, ENX1, Enhancer of zeste homolog 2, KMT6, KMT6A, Lysine N-methyltransferase 6, WVS2, Enhancer of zeste, ENX-1 -
Gen-ID
- 2146
-
Pathways
- Retinoic Acid Receptor Signaling Pathway, Regulation of Muscle Cell Differentiation
Target
-